Unjha Formul.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE576D01015
  • NSEID:
  • BSEID: 531762
INR
27.44
0.68 (2.54%)
BSENSE

Nov 20

BSE+NSE Vol: 1.13 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 782664,
    "name": "Unjha Formul.",
    "stock_name": "Unjha Formul.",
    "full_name": "Unjha Formulations Ltd",
    "name_url": "stocks-analysis/unjha-formul",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.44",
    "chg": 0.68,
    "chgp": "2.54%",
    "dir": 1,
    "prev_price": "26.76",
    "mcapval": "12.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531762,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE576D01015",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.13 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/unjha-formul-782664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Unjha Formulations Falls 3.16% Amid Valuation Shift and Mixed Q2 Results",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-falls-316-amid-valuation-shift-and-mixed-q2-results-4255509",
        "imagepath": "",
        "date": "2026-11-07 15:06:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Valuation shifts to fair amid sector comparisons</p>\n                    <p><strong>Nov 3:</strong> Continued price decline despite Sensex rally</p>\n                    <p><strong>Nov 4:</strong> Strong intraday recovery with volume surge</p>\n                    <p><strong>Nov 5:</strong> Further gains on positive market momentum</p>\n                    <p><strong>Nov 6:</strong> Q2 FY27 results show profit rebound but stock falls</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.28.45</div></div>\n                    <div class=\"stat-item\">..."
      },
      {
        "title": "Unjha Formulations Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-ltd-valuation-shift-enhances-price-attractiveness-amid-sector-challenges-4239894",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/UnjhaFormulatio_valuationdot_4239894.png",
        "date": "2026-10-27 08:01:07",
        "description": "Unjha Formulations Ltd has seen a notable shift in its valuation parameters, moving from fair to attractive territory despite recent market headwinds. This change reflects a recalibration of investor sentiment amid a challenging Pharmaceuticals & Biotechnology sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now offering a more compelling entry point relative to peers and historical averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 36.38",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs3638-4189458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4189458.png",
        "date": "2026-09-10 11:41:07",
        "description": "Surging past its previous peak, Unjha Formulations Ltd reached a fresh 52-week high of Rs 36.38 on 10 Sep 2026, propelled by a sustained rally that has delivered a 46.16% gain over the past ten trading sessions."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 35.39",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs3539-4188110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4188110.png",
        "date": "2026-09-09 10:43:54",
        "description": "After a sustained rally over the past nine sessions, Unjha Formulations Ltd surged to a fresh 52-week high of Rs 35.39 on 9 Sep 2026, marking a 42.19% gain since its recent low. This price milestone is underpinned by a confluence of bullish technical indicators and robust price momentum, setting the stock apart in a market environment where the broader Sensex has been under pressure."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 33.4",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs334-4186659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4186659.png",
        "date": "2026-09-08 10:36:51",
        "description": "With a decisive surge to Rs 33.4 on 8 Sep 2026, Unjha Formulations Ltd has reached a fresh 52-week high, marking a 91% rally from its low of Rs 17.52 over the past year. This milestone is underscored by a strong alignment of technical indicators and sustained price momentum, even as the broader market struggles to hold ground."
      },
      {
        "title": "Unjha Formulations Gains 17.30%: 4 Key Factors Driving the Surge",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-gains-1730-4-key-factors-driving-the-surge-4183676",
        "imagepath": "",
        "date": "2026-09-05 15:07:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Upgraded to Hold on Technical and Valuation Improvements</p>\n                    <p><strong>1 Sep:</strong> Downgraded to Sell amid Mixed Technicals and Fair Valuation</p>\n                    <p><strong>1 Sep:</strong> Valuation Shift Signals Caution Amid Strong Returns</p>\n                    <p><strong>4 Sep:</strong> Hits New 52-Week High at Rs.30.5</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.26.12</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.30.64</div><..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 30.5",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs305-4182604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4182604.png",
        "date": "2026-09-04 10:44:00",
        "description": "Surging to a fresh 52-week high of Rs 30.5 on 4 Sep 2026, Unjha Formulations Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market over the past week and beyond."
      },
      {
        "title": "Unjha Formulations Ltd: Valuation Shift Signals Caution Amid Strong Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/unjha-formulations-ltd-valuation-shift-signals-caution-amid-strong-returns-4176621",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_valuationdot_4176621.png",
        "date": "2026-09-01 08:00:41",
        "description": "Unjha Formulations Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade amid evolving market dynamics. This change reflects a recalibration of investor sentiment, driven by adjustments in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, when compared to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Unjha Formulations Ltd Upgraded to Hold on Technical and Valuation Improvements",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/unjha-formulations-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-4175454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/UnjhaFormulatio_mojoScore_4175454.png",
        "date": "2026-08-31 08:03:21",
        "description": "Unjha Formulations Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite flat recent financial performance. The upgrade, effective from 28 August 2026, is driven primarily by bullish technical trends, attractive valuation relative to peers, and a stable financial outlook, positioning the micro-cap pharmaceutical company for cautious optimism among investors."
      }
    ],
    "total": 29,
    "sid": "782664",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/unjha-formulations-782664"
  },
  "announcements": [
    {
      "caption": "Publish Audited Financial Results For The Quarter And Half Year Ended As On 30/09/2026",
      "datetime": "06-Nov-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": " Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2026 And Out Come Of Board Meeting Held On 5Th November 2026.",
      "datetime": "05-Nov-2026",
      "details": "REGULATION 33 OF SEBI (LODR) REGU 2015",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2026 And Out Come Of Board Meeting Held On 5Th November 2026.",
      "datetime": "05-Nov-2026",
      "details": "REGULATION 33 OF SEBI LODR REGU 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Publish Audited Financial Results For The Quarter And Half Year Ended As On 30/09/2026

06-Nov-2026 | Source : BSE

Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2026 And Out Come Of Board Meeting Held On 5Th November 2026.

05-Nov-2026 | Source : BSE

REGULATION 33 OF SEBI (LODR) REGU 2015

Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2026 And Out Come Of Board Meeting Held On 5Th November 2026.

05-Nov-2026 | Source : BSE

REGULATION 33 OF SEBI LODR REGU 2015

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available